Page last updated: 2024-08-16

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and pyrazines

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with pyrazines in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lugnier, C; Muller, B; Stoclet, JC1
Matsumori, A; Nose, Y; Ono, K; Sasayama, S; Sato, Y; Shioi, T1

Other Studies

2 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and pyrazines

ArticleYear
Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction.
    Journal of cardiovascular pharmacology, 1990, Volume: 16, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Atenolol; Calcium Chloride; Colforsin; Guinea Pigs; In Vitro Techniques; Male; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyrazines; Pyrrolidinones; Reserpine; Rolipram; Stereoisomerism; Xanthines

1990
Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Journal of molecular and cellular cardiology, 1996, Volume: 28, Issue:12

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 8-Bromo Cyclic Adenosine Monophosphate; Amrinone; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Heart Failure; Humans; Interleukin-1; Interleukin-6; Kinetics; Leukocytes, Mononuclear; Lipopolysaccharides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Pyrazines; Pyridazines; Quinazolines; Quinolines; Tumor Necrosis Factor-alpha

1996